DAFTAR PUSTAKA

1. Bennett, H.A., Einarson, A., Taddio, A., Koren, G. and Einarson, T.R.
(2004) Preva-lence of Depression during Pregnancy: Systematic
Review. Obstetrics and Gynecol-ogy, 103, 698-709.
https://doi.org/10.1097/01.AOG.0000116689.75396.5f

2. Stewart, D.E. (2011) Clinical Practice. Depression during Pregnancy.

The New Eng-land Journal of Medicine, 365, 1605-1611.
https://doi.org/10.1056/NEJMcp1102730

3. American College of Obstetricians and Gynecologists, Committee on

Obstetric Practice (2015) Committee Opinion No. 630: Screening for
Perinatal Depression. Obstetrics and Gynecology, 125, 1268-1271.
https://doi.org/10.1097/01.AOG.0000465192.34779.dc

4. Lai, C., Coulter, S.A. and Woodruff, A. (2017) Hypertension and

Pregnancy. Texas Heart Institute Journal, 44, 350-351.
https://doi.org/10.14503/THIJ-17-6359

5. American College of Obstetricians and Gynecologists, Task Force on

Hypertension in Pregnancy (2013) Hypertension in pregnancy. Report
of the American College of Obstetricians and Gynecologists’ Task
Force on Hypertension in Pregnancy. Obste-trics and Gynecology,
122, 1122-1131.

6. Kuklina, E.V., Ayala, C. and Callaghan, W.M. (2009) Hypertensive

Disorders and Severe Obstetric Morbidity in the United States.
Obstetrics & Gynecology, 113, 1299-1306.
https://doi.org/10.1097/AOG.0b013e3181a45b25

7. Katon, W.J., Russo, J.E., Melville, J.L., Katon, J.G. and Gavin, A.R.
(2012) Depres-sion in Pregnancy Is Associated with Preexisting but
Not Pregnancy-Induced Hypertension. General Hospital Psychiatry,
34, 9-16. https://doi.org/10.1016/j.genhosppsych.2011.09.018

1
 2

8. Kurki, T., Hiilesmaa, V., Raitasalo, R., Mattila, H. and Ylikorkala, O.

(2000) Depres-sion and Anxiety in Early Pregnancy and Risk for
Preeclampsia. Obstetrics & Gy-necology, 95, 487-490.

9. Ringoir, L., Pedersen, S.S., Widdershoven, J.W., Pouwer, F., Keyzer,

J.M., Romeijn-ders, A.C. and Pop, V.J. (2014) Beta-Blockers and
Depression in Elderly Hyperten-sion Patients in Primary Care. Family
Medicine, 46, 447-453.

10. Thiessen, B.Q., Wallace, S.M., Blackburn, J.L., Wilson, T.W. and
Bergman, U. (1990) Increased Prescribing of Antidepressants
Subsequent to Beta-Blocker Ther-apy. Archives of Internal Medicine,
150, 2286-2290.
https://doi.org/10.1001/archinte.1990.00390220044009

11. Waal, H.J. (1967) Propranolol-Induced Depression. British Medical

Journal, 2, 50. https://doi.org/10.1136/bmj.2.5543.50

12. Liu, X., Lou, X., Cheng, X. and Meng, Y. (2017) Impact of
Metoprolol Treatment on Mental Status of Chronic Heart Failure
Patients with Neuropsychiatric Disorders. Drug Design, Development
and Therapy, 11, 305-312. https://doi.org/10.2147/DDDT.S124497

13. Koella, W.P. (1985) CNS-Related (Side-)Effects of Beta-Blockers

with Special Ref-erence to Mechanisms of Action. European Journal
of Clinical Pharmacology, 28, 55-63.
https://doi.org/10.1007/BF00543711

14. Murray, L. and Carothers, A.D. (1990) The Validation of the

Edinburgh Post-Natal Depression Scale on a Community Sample. The
British Journal of Psychiatry, 157, 288-290.
https://doi.org/10.1192/bjp.157.2.288

15. Bergink, V., Kooistra, L., Lambregtse-van den Berg, M.P., Wijnen,
H., Bunevicius, R., van Baar, A. and Pop, V. (2011) Validation of the
 3

Edinburgh Depression Scale during Pregnancy. Journal of

Psychosomatic Research, 70, 385-389.
https://doi.org/10.1016/j.jpsychores.2010.07.008
16. Celano, C.M., Freudenreich, O., Fernandez-Robles, C., Stern, T.A.,
Caro, M.A. and Huffman, J.C. (2011) Depressogenic Effects of
Medications: A Review. Dialogues in Clinical Neuroscience, 13, 109-
125.

17. Igwe, M.N., Uwakwe, R., Ahanotu, C.A., Onyeama, G.M., Bakare,
M.O. and Ndu-kuba, A.C. (2013) Factors Associated with Depression
and Suicide among Patients with Diabetes Mellitus and Essential
Hypertension in a Nigerian Teaching Hospital. African Health
Sciences, 13, 68-77. https://doi.org/10.4314/ahs.v13i1.10

18. Munhoz, T.N., Nunes, B.P., Wehrmeister, F.C., Santos, I.S. and
Matijasevich, A. (2016) A Nationwide Population-Based Study of
Depression in Brazil. Journal of Affective Disorders, 192, 226-233.
https://doi.org/10.1016/j.jad.2015.12.038

19. Carney, R.M. and Freedland, K.E. (2008) Depression in Patients with
Coronary Heart Disease. American Journal of Medicine, 121, S20-
S27. https://doi.org/10.1016/j.amjmed.2008.09.010
20. Miller, A.H. and Raison, C.L. (2016) The Role of Inflammation in
Depression: From Evolutionary Imperative to Modern Treatment
Target. Nature Reviews Immunolo-gy, 16, 22-34.
https://doi.org/10.1038/nri.2015.5

21. Aschbacher, K., Epel, E., Wolkowitz, O.M., Prather, A.A., Puterman,
E. and Dhab-har, F.S. (2012) Maintenance of a Positive Outlook
during Acute Stress Protects against Pro-Inflammatory Reactivity and
Future Depressive Symptoms. Brain, Be-havior, and Immunity, 26,
346-352. https://doi.org/10.1016/j.bbi.2011.10.010

22. Buglione-Corbett, R., Deligiannidis, K.M., Leung, K., Zhang, N., Lee,
M., Rosal, M.C. and Moore Simas, T.A. (2018) Expression of
 4

Inflammatory Markers in Wom-en with Perinatal Depressive

Symptoms. Archives of Women’s Mental Health.

23. Simpson, W., Steiner, M., Coote, M. and Frey, B.N. (2016)
Relationship between In-flammatory Biomarkers and Depressive
Symptoms during Late Pregnancy and the Early Postpartum Period: A
Longitudinal Study. Revista Brasileira de Psiquiatria, 38, 190-196.
https://doi.org/10.1590/1516-4446-2015-1899

24. Hallas, J. (1996) Evidence of Depression Provoked by Cardiovascular

Medication: A Prescription Sequence Symmetry Analysis.
Epidemiology, 7, 478-484. https://doi.org/10.1097/00001648-
199609000-00005

25. Avorn, J., Everitt, D.E. and Weiss, S. (1986) Increased Antidepressant
Use in Pa-tients Prescribed Beta-Blockers. JAMA, 255, 357-360.
https://doi.org/10.1001/jama.1986.03370030077031

26. Ko, D.T., Hebert, P.R., Coffey, C.S., Sedrakyan, A., Curtis, J.P. and
Krumholz, H.M. (2002) Beta-Blocker Therapy and Symptoms of
Depression, Fatigue, and Sexual Dysfunction. JAMA, 288, 351-357.
https://doi.org/10.1001/jama.288.3.351
27. Fitton, C.A., Steiner, M.F.C., Aucott, L., Pell, J.P., Mackay, D.F.,
Fleming, M. and McLay, J.S. (2017) In-Utero Exposure to
Antihypertensive Medication and Neonatal and Child Health
Outcomes: A Systematic Review. Journal of Hypertension, 35, 2123-
2137. https://doi.org/10.1097/HJH.0000000000001456

28. Richards, D.A., Tuckman, J. and Prichard, B.N. (1976) Assessment of

Alpha- and Beta-Adrenoceptor Blocking Actions of Labetalol. British
Journal of Clinical Phar-macology, 3, 849-855.
https://doi.org/10.1111/j.1365-2125.1976.tb00637.x

29. Lydakis, C., Lip, G.Y., Beevers, M. and Beevers, D.G. (1999)
Atenolol and Fetal Growth in Pregnancies Complicated by
 5

Hypertension. American Journal of Hyper-tension, 12, 541-547.

https://doi.org/10.1016/S0895-7061(99)00031-X
30. Poirier, L. and Tobe, S.W. (2014) Contemporary Use of Beta-
Blockers: Clinical Re-levance of Subclassification. Canadian Journal
of Cardiology, 30, S9-S15. https://doi.org/10.1016/j.cjca.2013.12.001

31. Straub, H., Adams, M. and Silver, R.K. (2014) Can an Electronic
Health Record System Be Used for Preconception Health
Optimization? Maternal and Child Health Journal, 18, 2134-2140.
https://doi.org/10.1007/s10995-014-1461-8